乳腺癌患者管理中的争议：绝经前女性的辅助内分泌治疗 - Suppr

Suppr

超能文献

Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.

作者信息

Parton Marina, Smith Ian E

机构信息

Breast Unit, The Royal Marsden Hospital, Institute of Cancer Research, London, United Kingdom.

出版信息

J Clin Oncol. 2008 Feb 10;26(5):745-52. doi: 10.1200/JCO.2007.14.3016.

DOI:10.1200/JCO.2007.14.3016

PMID:18258982

Abstract

摘要

相似文献

Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.乳腺癌患者管理中的争议：绝经前女性的辅助内分泌治疗

J Clin Oncol. 2008 Feb 10;26(5):745-52. doi: 10.1200/JCO.2007.14.3016.

Adjuvant endocrine therapy in premenopausal women with breast cancer.绝经前乳腺癌女性的辅助内分泌治疗

Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:43-7. doi: 10.1007/s10549-010-1045-2. Epub 2010 Aug 14.

Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.辅助内分泌治疗随机试验中早期乳腺癌绝经前女性的骨矿物质密度

J Clin Oncol. 2004 Sep 15;22(18):3694-9. doi: 10.1200/JCO.2004.08.148.

[Hormone therapy in breast cancer: the end of tamoxifen?].

Bull Cancer. 2005 Feb;92(2):142-50.

Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.绝经前雌激素受体阳性乳腺癌患者的卵巢抑制/切除。问题与建议。

Oncology (Williston Park). 2009 Jan;23(1):27-33.

Adjuvant endocrine therapy for premenopausal women with early breast cancer.早期乳腺癌绝经前女性的辅助内分泌治疗。

J Clin Oncol. 2005 Mar 10;23(8):1736-50. doi: 10.1200/JCO.2005.11.050.

Adjuvant endocrine therapy for perimenopausal women with early breast cancer.围绝经期早期乳腺癌女性的辅助内分泌治疗。

Breast. 2009 Feb;18(1):2-7. doi: 10.1016/j.breast.2008.10.002. Epub 2008 Nov 26.

Which is the appropriate adjuvant endocrine therapy for premenopausal patients with breast cancer?对于绝经前乳腺癌患者，哪种辅助内分泌治疗是合适的？

Clin Breast Cancer. 2015 Jun;15(3):169-70. doi: 10.1016/j.clbc.2014.12.008. Epub 2014 Dec 24.

The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.早期乳腺癌辅助激素治疗的最佳持续时间。

Clin Adv Hematol Oncol. 2008 Aug;6(8):573-4.

Adjuvant endocrine therapy for premenopausal women with hormone-responsive breast cancer.激素受体阳性乳腺癌绝经前女性的辅助内分泌治疗。

Breast. 2015 Nov;24 Suppl 2:S120-5. doi: 10.1016/j.breast.2015.07.027.

引用本文的文献

An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management.他莫昔芬与维生素E在乳腺癌治疗中的化学预防潜力的最新进展。

J Pers Med. 2023 Apr 28;13(5):754. doi: 10.3390/jpm13050754.

Cancer Treatment-Induced Bone Loss in Women With Breast Cancer and Men With Prostate Cancer.乳腺癌女性和前列腺癌男性的癌症治疗引起的骨质流失

J Endocr Soc. 2018 May 21;2(7):574-588. doi: 10.1210/js.2018-00052. eCollection 2018 Jul 1.

Tamoxifen Initiation After Ductal Carcinoma In Situ.导管原位癌后他莫昔芬的起始治疗

Oncologist. 2016 Feb;21(2):134-40. doi: 10.1634/theoncologist.2015-0310. Epub 2016 Jan 14.

Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide.4-羟基-N-去甲他莫昔芬和他莫昔芬-N-氧化物的组织分布。

Breast Cancer Res Treat. 2012 Jul;134(2):693-700. doi: 10.1007/s10549-012-2074-9. Epub 2012 May 5.

Pharmacoeconomic considerations in the treatment of breast cancer.乳腺癌治疗中的药物经济学考量

Clinicoecon Outcomes Res. 2010;2:47-61. Epub 2010 Jun 15.

Is Chemoendocrine Treatment without Alternative?化学内分泌治疗是唯一选择吗？

Breast Care (Basel). 2008;3(4):231-235. doi: 10.1159/000149558. Epub 2008 Aug 22.

An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.激素受体阳性早期乳腺癌辅助内分泌治疗疗效的更新评价。

Curr Oncol. 2009 Jul;16 Suppl 2(Suppl 2):S1-13. doi: 10.3747/co.v16i0.455.

Genotype-guided tamoxifen therapy: time to pause for reflection?基因分型指导的他莫昔芬治疗：是时候停下来反思了？

Lancet Oncol. 2009 Aug;10(8):825-33. doi: 10.1016/S1470-2045(09)70030-0.

CYP2D6 and tamoxifen: DNA matters in breast cancer.细胞色素P450 2D6与他莫昔芬：DNA在乳腺癌中的重要作用

Nat Rev Cancer. 2009 Aug;9(8):576-86. doi: 10.1038/nrc2683.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验